Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidences of chronic pain and cardiovascular diseases
3.2.1.2 Increasing number of surgery procedures
3.2.1.3 Advancements in drug delivery systems
3.2.1.4 Increasing preference for anesthetics over opioids
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects associated with lidocaine
3.2.2.2 Stringent regulatory complexities
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Regulatory landscape
3.6 Porters analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Creams
5.3 Patches
5.4 Injectables
5.5 Other dosage forms
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Cardiology
6.3 Dental procedures
6.4 Epilepsy
6.5 Dermatological procedures
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Generics
7.3 Branded
Chapter 8 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Clinics
8.4 Ambulatory surgical centers (ASCs)
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AdvaCare Pharma
10.2 Amneal Pharmaceuticals LLC
10.3 AstraZeneca Plc.
10.4 B. Braun Melsungen AG
10.5 Endo Pharmaceuticals Inc.
10.6 Fresenius SE & Co. KGaA
10.7 F. Hoffmann-La Roche Ltd.
10.8 Gensco Pharma
10.9 Glenmark Pharmaceuticals
10.10 Guanlang Group
10.11 Hisamitsu Pharmaceutical Co., Inc.
10.12 Mylan N.V.
10.13 PAI Pharma.
10.14 Pfizer Inc.
10.15 Scilex Holding Company
10.16 Septodont Healthcare India Pvt. Ltd.
10.17 Taro Pharmaceutical Industries Ltd.
